Essentia BioSciences
意胜生物
Essentia BioSciences
Biotech/Healthcare
Founded in late 2021, Essentia BioSciences is an innovative cell therapy developer focused on differentiating pluripotent stem cells into pancreatic islet tissue. Its goal is to regenerate healthy islet tissue in vitro from pluripotent stem cells and address insulin-dependent diabetes at its source.
Latest round: Pre Series A (2026)
Source: ChinaBulls — chinabulls.com
Last updated 2026-01-01
Funding history
Request access to view this section.
Investors
Request access to view this section.
HQ & website
Request access to view this section.
Tags
Request access to view this section.